Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death

Journal of the Neurological Sciences

Volumn 278, Issue 1-2, 2009, Pages 5-15

  Jana, Arundhati ^a   Hogan, Edward L ^b   Pahan, Kalipada ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Ceramide; Glial activation; Neurodegenerative disorders; Neuronal apoptosis; Oligodendroglial death; Signal transduction; Sphingomyelinases

Indexed keywords

ANTIOXIDANT; CERAMIDE; CYTOKINE; DEATH ASSOCIATED PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; NEUROTOXIN; PHOSPHOPROTEIN PHOSPHATASE 2A; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; UNSATURATED FATTY ACID; VIRUS PROTEIN;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ASTROCYTE; BRAIN MITOCHONDRION; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPID RAFT; LIPOGENESIS; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROKE;

AGING; APOPTOSIS; CELL DIFFERENTIATION; CERAMIDES; CYTOKINES; HUMANS; MEMBRANE MICRODOMAINS; MITOCHONDRIA; NERVE DEGENERATION; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTOXINS; OLIGODENDROGLIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SPHINGOMYELINS;

EID: 58849160520     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.010     Document Type: Review

References (171)

1. Kolson D.L., and Gonzalez-Scarano F. Hiv and hiv dementia. J Clin Invest 106 (2000) 11-13
2. Martin J.B. Molecular basis of the neurodegenerative disorders. N Engl J Med 340 (1999) 1970-1980
3. Morales A., Lee H., Goni F.M., Kolesnick R., and Fernandez-Checa J.C. Sphingolipids and cell death. Apoptosis 12 (2007) 923-939
4. Yuan J., and Yankner B.A. Apoptosis in the nervous system. Nature 407 (2000) 802-809
5. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and alzheimer's disease. Proc Natl Acad Sci U S A 101 (2004) 2070-2075
6. Ariga T., Jarvis W.D., and Yu R.K. Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39 (1998) 1-16
7. Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., and Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52 (2002) 448-457
8. Lee J.T., Xu J., Lee J.M., Ku G., Han X., Yang D.I., et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164 (2004) 123-131
9. Sribney M., and Kennedy E.P. The enzymatic synthesis of sphingomyelin. J Biol Chem 233 (1958) 1315-1322
10. Voelker D.R., and Kennedy E.P. Cellular and enzymic synthesis of sphingomyelin. Biochemistry 21 (1982) 2753-2759
11. Hannun Y.A., and Bell R.M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243 (1989) 500-507
12. Kolesnick R., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
13. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269 (1994) 3125-3128
14. Futerman A.H., and Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep 5 (2004) 777-782
15. Zhang Y., and Kolesnick R. Signaling through the sphingomyelin pathway. Endocrinology 136 (1995) 4157-4160
16. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 274 (1996) 1855-1859
17. Tsui-Pierchala B.A., Encinas M., Milbrandt J., and Johnson Jr. E.M. Lipid rafts in neuronal signaling and function. Trends Neurosci 25 (2002) 412-417
18. Paratcha G., and Ibanez C.F. Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr Opin Neurobiol 12 (2002) 542-549
19. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14 (1998) 111-136
20. Venkataraman K., and Futerman A.H. Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol 10 (2000) 408-412
21. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., and Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem J 369 (2003) 199-211
22. Suzuki T. Lipid rafts at postsynaptic sites: distribution, function and linkage to postsynaptic density. Neurosci Res 44 (2002) 1-9
23. Chamberlain L.H., Burgoyne R.D., and Gould G.W. Snare proteins are highly enriched in lipid rafts in pc12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci U S A 98 (2001) 5619-5624
24. Vinson M., Rausch O., Maycox P.R., Prinjha R.K., Chapman D., Morrow R., et al. Lipid rafts mediate the interaction between myelin-associated glycoprotein (mag) on myelin and mag-receptors on neurons. Mol Cell Neurosci 22 (2003) 344-352
25. Prinetti A., Chigorno V., Prioni S., Loberto N., Marano N., Tettamanti G., et al. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 276 (2001) 21136-21145
26. Hering H., Lin C.C., and Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface ampa receptor stability. J Neurosci 23 (2003) 3262-3271
27. Bansal R., Gard A.L., and Pfeiffer S.E. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J Neurosci Res 21 (1988) 260-267
28. Greenfield S., Brostoff S., and Hogan E. Evidence for defective incorporation of proteins in myelin of the quaking mutant mouse. Brain Res 120 (1977) 507-515
29. Trapp B.D., and Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 31 (2008) 247-269
30. Bansal R., and Pfeiffer S.E. Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci U S A 86 (1989) 6181-6185
31. Schwarz A., and Futerman A.H. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J Neurosci 17 (1997) 2929-2938
32. Furuya S., Mitoma J., Makino A., and Hirabayashi Y. Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar purkinje cells. J Neurochem 71 (1998) 366-377
33. Schwarz A., Rapaport E., Hirschberg K., and Futerman A.H. A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J Biol Chem 270 (1995) 10990-10998
34. Seufferlein T., and Rozengurt E. Sphingosine induces p125fak and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3t3 cells. J Biol Chem 269 (1994) 27610-27617
35. Brann A.B., Scott R., Neuberger Y., Abulafia D., Boldin S., Fainzilber M., et al. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J Neurosci 19 (1999) 8199-8206
36. Han X., D M.H., McKeel Jr. D.W., Kelley J., and Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82 (2002) 809-818
37. Alessenko A.V., Bugrova A.E., and Dudnik L.B. Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease. Biochem Soc Trans 32 (2004) 144-146
38. Puglielli L., Ellis B.C., Saunders A.J., and Kovacs D.M. Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem 278 (2003) 19777-19783
39. Haughey N.J., Cutler R.G., Tamara A., McArthur J.C., Vargas D.L., Pardo C.A., et al. Perturbation of sphingolipid metabolism and ceramide production in hiv-dementia. Ann Neurol 55 (2004) 257-267
40. Jana A., and Pahan K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2 (2007) 184-193
41. Pehar M., Vargas M.R., Robinson K.M., Cassina P., Diaz-Amarilla P.J., Hagen T.M., et al. Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. J Neurosci 27 (2007) 7777-7785
42. Yu Z.F., Nikolova-Karakashian M., Zhou D., Cheng G., Schuchman E.H., and Mattson M.P. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15 (2000) 85-97
43. Takahashi K., Ginis I., Nishioka R., Klimanis D., Barone F.C., White R.F., et al. Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning. J Cereb Blood Flow Metab 24 (2004) 623-627
44. Ohtani R., Tomimoto H., Kondo T., Wakita H., Akiguchi I., Shibasaki H., et al. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res 1023 (2004) 31-40
45. Puranam K., Qian W.H., Nikbakht K., Venable M., Obeid L., Hannun Y., et al. Upregulation of bcl-2 and elevation of ceramide in batten disease. Neuropediatrics 28 (1997) 37-41
46. Denisova N.A., Cantuti-Castelvetri I., Hassan W.N., Paulson K.E., and Joseph J.A. Role of membrane lipids in regulation of vulnerability to oxidative stress in pc12 cells: implication for aging. Free Radic Biol Med 30 (2001) 671-678
47. Costantini C., Weindruch R., Della Valle G., and Puglielli L. A trka-to-p75ntr molecular switch activates amyloid beta-peptide generation during aging. Biochem J 391 (2005) 59-67
48. Ditaranto-Desimone K., Saito M., Tekirian T.L., Berg M., Dubowchik G., Soreghan B., et al. Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide. Brain Res Bull 59 (2003) 523-531
49. de Chaves E.P., Bussiere M., MacInnis B., Vance D.E., Campenot R.B., and Vance J.E. Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons. J Biol Chem 276 (2001) 36207-36214
50. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., et al. Cns synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
51. Matsumoto S., Friberg H., Ferrand-Drake M., and Wieloch T. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 19 (1999) 736-741
52. Kolesnick R.N., and Kronke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 60 (1998) 643-665
53. Ghafourifar P., Klein S.D., Schucht O., Schenk U., Pruschy M., Rocha S., et al. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J Biol Chem 274 (1999) 6080-6084
54. Stoica B.A., Movsesyan V.A., Lea P.M.t., and Faden A.I. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of akt, bad, fkhr, gsk-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci 22 (2003) 365-382
55. Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., et al. Opposite regulation of the mitochondrial apoptotic pathway by c2-ceramide and pacap through a map-kinase-dependent mechanism in cerebellar granule cells. J Neurochem 91 (2004) 1231-1243
56. Movsesyan V.A., Yakovlev A.G., Dabaghyan E.A., Stoica B.A., and Faden A.I. Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem Biophys Res Commun 299 (2002) 201-207
57. Poppe M., Reimertz C., Munstermann G., Kogel D., and Prehn J.H. Ceramide-induced apoptosis of d283 medulloblastoma cells requires mitochondrial respiratory chain activity but occurs independently of caspases and is not sensitive to bcl-xl overexpression. J Neurochem 82 (2002) 482-494
58. France-Lanord V., Brugg B., Michel P.P., Agid Y., and Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in parkinson's disease. J Neurochem 69 (1997) 1612-1621
59. Darios F., Lambeng N., Troadec J.D., Michel P.P., and Ruberg M. Ceramide increases mitochondrial free calcium levels via caspase 8 and bid: role in initiation of cell death. J Neurochem 84 (2003) 643-654
60. Melchiorri D., Martini F., Lococo E., Gradini R., Barletta E., De Maria R., et al. An early increase in the disialoganglioside gd3 contributes to the development of neuronal apoptosis in culture. Cell Death Differ 9 (2002) 609-615
61. Feinstein E., Kimchi A., Wallach D., Boldin M., and Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci 20 (1995) 342-344
62. Shohat G., Spivak-Kroizman T., Cohen O., Bialik S., Shani G., Berrisi H., et al. The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J Biol Chem 276 (2001) 47460-47467
63. Yamamoto M., Takahashi H., Nakamura T., Hioki T., Nagayama S., Ooashi N., et al. Developmental changes in distribution of death-associated protein kinase mrnas. J Neurosci Res 58 (1999) 674-683
64. Yamamoto M., Hioki T., Ishii T., Nakajima-Iijima S., and Uchino S. Dap kinase activity is critical for c(2)-ceramide-induced apoptosis in pc12 cells. Eur J Biochem 269 (2002) 139-147
65. Pelled D., Raveh T., Riebeling C., Fridkin M., Berissi H., Futerman A.H., et al. Death-associated protein (dap) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem 277 (2002) 1957-1961
66. Dobrowsky R.T., Kamibayashi C., Mumby M.C., and Hannun Y.A. Ceramide activates heterotrimeric protein phosphatase 2a. J Biol Chem 268 (1993) 15523-15530
67. Dobrowsky R.T., and Hannun Y.A. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 267 (1992) 5048-5051
68. Law B., and Rossie S. The dimeric and catalytic subunit forms of protein phosphatase 2a from rat brain are stimulated by c2-ceramide. J Biol Chem 270 (1995) 12808-12813
69. Salinas M., Lopez-Valdaliso R., Martin D., Alvarez A., and Cuadrado A. Inhibition of pkb/akt1 by c2-ceramide involves activation of ceramide-activated protein phosphatase in pc12 cells. Mol Cell Neurosci 15 (2000) 156-169
70. Ruvolo P.P., Deng X., Ito T., Carr B.K., and May W.S. Ceramide induces bcl2 dephosphorylation via a mechanism involving mitochondrial pp2a. J Biol Chem 274 (1999) 20296-20300
71. Moore A.N., Kampfl A.W., Zhao X., Hayes R.L., and Dash P.K. Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes. Neuroscience 94 (1999) 405-415
72. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14 (1995) 927-939
73. Estus S., Zaks W.J., Freeman R.S., Gruda M., Bravo R., and Johnson E.M. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127 (1994) 1717-1727
74. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of erk and jnk-p38 map kinases on apoptosis. Science 270 (1995) 1326-1331
75. Plummer G., Perreault K.R., Holmes C.F., and Posse De Chaves E.I. Activation of serine/threonine protein phosphatase-1 is required for ceramide-induced survival of sympathetic neurons. Biochem J 385 (2005) 685-693
76. Ferguson K.L., and Slack R.S. The rb pathway in neurogenesis. Neuroreport 12 (2001) A55-62
77. Dbaibo G.S., Pushkareva M.Y., Jayadev S., Schwarz J.K., Horowitz J.M., Obeid L.M., et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci U S A 92 (1995) 1347-1351
78. Manev H., and Cagnoli C.M. Ceramide-mediated and isoquinolinesulfonamide-sensitive pathways of neuronal death: anything in common?. Neurochem Int 31 (1997) 203-206
79. Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker Jr. W.D., Sturgill T.W., et al. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappab in cellular models of Parkinson's disease. J Neurochem 74 (2000) 1384-1392
80. Chun H.S., Gibson G.E., DeGiorgio L.A., Zhang H., Kidd V.J., and Son J.H. Dopaminergic cell death induced by mpp(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76 (2001) 1010-1021
81. Harper S.J., and LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, jnk and p38. Cell Signal 13 (2001) 299-310
82. Saporito M.S., Thomas B.A., and Scott R.W. Mptp activates c-jun nh(2)-terminal kinase (jnk) and its upstream regulatory kinase mkk4 in nigrostriatal neurons in vivo. J Neurochem 75 (2000) 1200-1208
83. Kuan C.Y., Whitmarsh A.J., Yang D.D., Liao G., Schloemer A.J., Dong C., et al. A critical role of neural-specific jnk3 for ischemic apoptosis. Proc Natl Acad Sci U S A 100 (2003) 15184-15189
84. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the jnk3 gene. Nature 389 (1997) 865-870
85. Soeda S., Tsuji Y., Ochiai T., Mishima K., Iwasaki K., Fujiwara M., et al. Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress. Neurochem Int 45 (2004) 619-626
86. Borsello T., and Forloni G. Jnk signalling: a possible target to prevent neurodegeneration. Curr Pharm Des 13 (2007) 1875-1886
87. Davis R.J. Signal transduction by the jnk group of map kinases. Cell 103 (2000) 239-252
88. Willaime-Morawek S., Brami-Cherrier K., Mariani J., Caboche J., and Brugg B. C-jun n-terminal kinases/c-jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 119 (2003) 387-397
89. Choi H.J., Lee S.Y., Cho Y., and Hwang O. Jnk activation by tetrahydrobiopterin: implication for Parkinson's disease. J Neurosci Res 75 (2004) 715-721
90. Brann A.B., Tcherpakov M., Williams I.M., Futerman A.H., and Fainzilber M. Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J Biol Chem 277 (2002) 9812-9818
91. Willaime S., Vanhoutte P., Caboche J., Lemaigre-Dubreuil Y., Mariani J., and Brugg B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in erk phosphorylation. Eur J Neurosci 13 (2001) 2037-2046
92. Hida H., Nagano S., Takeda M., and Soliven B. Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes. J Neurosci 19 (1999) 7458-7467
93. Levade T., Moser H.W., Fensom A.H., Harzer K., Moser A.B., and Salvayre R. Neurodegenerative course in ceramidase deficiency (farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells. J Neurol Sci 134 (1995) 108-114
94. Maimone D., Gregory S., Arnason B.G., and Reder A.T. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32 (1991) 67-74
95. Trotter J.L., Collins K.G., and van der Veen R.C. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels. J Neuroimmunol 33 (1991) 29-36
96. Tsukada N., Miyagi K., Matsuda M., Yanagisawa N., and Yone K. Tumor necrosis factor and interleukin-1 in the csf and sera of patients with multiple sclerosis. J Neurol Sci 104 (1991) 230-234
97. Peter J.B., Boctor F.N., and Tourtellotte W.W. Serum and csf levels of il-2, sil-2r, tnf-alpha, and il-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 41 (1991) 121-123
98. Gallo P., Piccinno M.G., Krzalic L., and Tavolato B. Tumor necrosis factor alpha (tnf alpha) and neurological diseases. Failure in detecting tnf alpha in the cerebrospinal fluid from patients with multiple sclerosis, aids dementia complex, and brain tumours. J Neuroimmunol 23 (1989) 41-44
99. Richard A., Robichaud G., Lapointe R., Bourgoin S., Darveau A., and Poulin L. Interference of hiv-1 nef in the sphingomyelin transduction pathway activated by tumour necrosis factor-alpha in human glial cells. Aids 11 (1997) F1-7
100. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
101. Chakraborty G., Ziemba S., Drivas A., and Ledeen R.W. Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. J Neurosci Res 50 (1997) 466-476
102. Ledeen R.W., and Chakraborty G. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis. Neurochem Res 23 (1998) 277-289
103. Scurlock B., and Dawson G. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J Neurosci Res 55 (1999) 514-522
104. Sortino M.A., Condorelli F., Vancheri C., and Canonico P.L. Tumor necrosis factor-alpha induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways. Endocrinology 140 (1999) 4841-4849
105. Mayne M., Bratanich A.C., Chen P., Rana F., Nath A., and Power C. Hiv-1 tat molecular diversity and induction of tnf-alpha: implications for hiv-induced neurological disease. Neuroimmunomodulation 5 (1998) 184-192
106. Jeohn G.H., Kong L.Y., Wilson B., Hudson P., and Hong J.S. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85 (1998) 1-10
107. Perry S.W., Hamilton J.A., Tjoelker L.W., Dbaibo G., Dzenko K.A., Epstein L.G., et al. Platelet-activating factor receptor activation. An initiator step in hiv-1 neuropathogenesis. J Biol Chem 273 (1998) 17660-17664
108. Fine S.M., Angel R.A., Perry S.W., Epstein L.G., Rothstein J.D., Dewhurst S., et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of hiv-1 dementia. J Biol Chem 271 (1996) 15303-15306
109. Choi D.W. Excitotoxic cell death. J Neurobiol 23 (1992) 1261-1276
110. Wong P.C., Rothstein J.D., and Price D.L. The genetic and molecular mechanisms of motor neuron disease. Curr Opin Neurobiol 8 (1998) 791-799
111. Samuels A. Excitatory amino acids in neurologic disorders. N Engl J Med 331 (1994) 274-275
112. Starkov A.A., Chinopoulos C., and Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 36 (2004) 257-264
113. Malaplate-Armand C., Florent-Bechard S., Youssef I., Koziel V., Sponne I., Kriem B., et al. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cpla(2)-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis (2006)
114. Eddleston M., and Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 54 (1993) 15-36
115. Schinder A.F., and Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 23 (2000) 639-645
116. Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77 (1994) 627-638
117. Crutcher K.A., Scott S.A., Liang S., Everson W.V., and Weingartner J. Detection of ngf-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13 (1993) 2540-2550
118. Fahnestock M., Scott S.A., Jette N., Weingartner J.A., and Crutcher K.A. Nerve growth factor mrna and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Brain Res Mol Brain Res 42 (1996) 175-178
119. Akundi R.S., Candelario-Jalil E., Hess S., Hull M., Lieb K., Gebicke-Haerter P.J., et al. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 51 (2005) 199-208
120. Hostetler K.Y., and Yazaki P.J. The subcellular localization of neutral sphingomyelinase in rat liver. J Lipid Res 20 (1979) 456-463
121. Ferlinz K., Hurwitz R., Vielhaber G., Suzuki K., and Sandhoff K. Occurrence of two molecular forms of human acid sphingomyelinase. Biochem J 301 Pt 3 (1994) 855-862
122. Gatt S. Magnesium-dependent sphingomyelinase. Biochem Biophys Res Commun 68 (1976) 235-241
123. Yamaguchi S., and Suzuki K. A novel magnesium-independent neutral sphingomyelinase associated with rat central nervous system meylin. J Biol Chem 253 (1978) 4090-4092
124. Duan R.D., Nyberg L., and Nilsson A. Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristics. Biochim Biophys Acta 1259 (1995) 49-55
125. Wiegmann K., Schutze S., Machleidt T., Witte D., and Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78 (1994) 1005-1015
126. Liu B., Hassler D.F., Smith G.K., Weaver K., and Hannun Y.A. Purification and characterization of a membrane bound neutral ph optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J Biol Chem 273 (1998) 34472-34479
127. Bernardo K., Krut O., Wiegmann K., Kreder D., Micheli M., Schafer R., et al. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain. J Biol Chem 275 (2000) 7641-7647
128. Jung S.Y., Suh J.H., Park H.J., Jung K.M., Kim M.Y., Na D.S., et al. Identification of multiple forms of membrane-associated neutral sphingomyelinase in bovine brain. J Neurochem 75 (2000) 1004-1014
129. Blochl A., and Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via trk and p75lntr receptors. J Biol Chem 271 (1996) 21100-21107
130. Bajjalieh S.M., Martin T.F., and Floor E. Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J Biol Chem 264 (1989) 14354-14360
131. Chao M.V. Ceramide: a potential second messenger in the nervous system. Mol Cell Neurosci 6 (1995) 91-96
132. Knipper M., Leung L.S., Zhao D., and Rylett R.J. Short-term modulation of glutamatergic synapses in adult rat hippocampus by ngf. Neuroreport 5 (1994) 2433-2436
133. Jayadev S., Linardic C.M., and Hannun Y.A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 269 (1994) 5757-5763
134. Jayadev S., Hayter H.L., Andrieu N., Gamard C.J., Liu B., Balu R., et al. Phospholipase a2 is necessary for tumor necrosis factor alpha-induced ceramide generation in l929 cells. J Biol Chem 272 (1997) 17196-17203
135. Liu B., and Hannun Y.A. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272 (1997) 16281-16287
136. Yoshimura S., Banno Y., Nakashima S., Hayashi K., Yamakawa H., Sawada M., et al. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic pc12 cell death. J Neurochem 73 (1999) 675-683
137. Jana A., and Pahan K. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J Neurosci 24 (2004) 9531-9540
138. Jana A., and Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via nadph oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 279 (2004) 51451-51459
139. Singh I., Pahan K., Khan M., and Singh A.K. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273 (1998) 20354-20362
140. Mao C., Xu R., Szulc Z.M., Bielawska A., Galadari S.H., and Obeid L.M. Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276 (2001) 26577-26588
141. Mitsutake S., Tani M., Okino N., Mori K., Ichinose S., Omori A., et al. Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem 276 (2001) 26249-26259
142. Koch J., Gartner S., Li C.M., Quintern L.E., Bernardo K., Levran O., et al. Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing farber disease. J Biol Chem 271 (1996) 33110-33115
143. El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J.J., and Hannun Y.A. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 275 (2000) 21508-21513
144. Klein J.A., and Ackerman S.L. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111 (2003) 785-793
145. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 59 (1992) 1609-1623
146. Culotta V.C., Yang M., and O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 1763 (2006) 747-758
147. Mo J.Q., Hom D.G., and Andersen J.K. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech Ageing Dev 81 (1995) 73-82
148. Baek B.S., Kwon H.J., Lee K.H., Yoo M.A., Kim K.W., Ikeno Y., et al. Regional difference of ros generation, lipid peroxidation, and antioxidant enzyme activity in rat brain and their dietary modulation. Arch Pharm Res 22 (1999) 361-366
149. Thorburne S.K., and Juurlink B.H. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67 (1996) 1014-1022
150. Juurlink B.H., Thorburne S.K., and Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22 (1998) 371-378
151. Juurlink B.H., Schultke E., and Hertz L. Glutathione release and catabolism during energy substrate restriction in astrocytes. Brain Res 710 (1996) 229-233
152. Chatterjee S., Noack H., Possel H., Keilhoff G., and Wolf G. Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia 27 (1999) 152-161
153. Frankel D., Mehindate K., and Schipper H.M. Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J Cell Physiol 185 (2000) 80-86
154. Fox R.M., Jones J.E., and Atterwill C.K. Gliotoxicity in brain reaggregate cultures caused by oxidants and excitatory amino acids can be prevented by alpha-tocopherol and mk-801. Neurotoxicology 17 (1996) 705-710
155. Saha R.N., and Pahan K. Differential regulation of mn-superoxide dismutase in neurons and astroglia by hiv-1 gp120: implications for hiv-associated dementia. Free Radic Biol Med 42 (2007) 1866-1878
156. Pahan K., Dobashi K., Ghosh B., and Singh I. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. J Neurochem 73 (1999) 513-520
157. Manna S.K., Sah N.K., and Aggarwal B.B. Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of nf-kappa b, ap-1, jnk, and apoptosis. J Biol Chem 275 (2000) 13297-13306
158. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5 (2004) 863-873
159. Beard J. Recent evidence from human and animal studies regarding iron status and infant development. J Nutr 137 (2007) 524S-530S
160. Zhang X., Haaf M., Todorich B., Grosstephan E., Schieremberg H., Surguladze N., et al. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52 (2005) 199-208
161. Connor J.R., and Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 17 (1996) 83-93
162. LeVine S.M. Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J Neurosci Res 29 (1991) 413-419
163. Beard J.L., Wiesinger J.A., and Connor J.R. Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci 25 (2003) 308-315
164. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and alzheimer's disease. Neurobiol Aging 25 (2004) 5-18 author reply 49-62
165. Ferriero D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 23 (2001) 198-202
166. Gaasch J.A., Lockman P.R., Geldenhuys W.J., Allen D.D., and Van der Schyf C.J. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 32 (2007) 1196-1208
167. Dringen R., Bishop G.M., Koeppe M., Dang T.N., and Robinson S.R. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32 (2007) 1884-1890
168. Moos T., Rosengren Nielsen T., Skjorringe T., and Morgan E.H. Iron trafficking inside the brain. J Neurochem 103 (2007) 1730-1740
169. Schonfeld E., Yasharel I., Yavin E., and Brand A. Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in pc12 cells. Neurochem Res 32 (2007) 1673-1684
170. Brand A., Schonfeld E., Isharel I., and Yavin E. Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage. J Neurochem 105 (2008) 1325-1335
171. Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 44 (2003) 2221-2233